309 related articles for article (PubMed ID: 15225804)
1. Differential biological effects of 1,25-dihydroxyVitamin D3 on melanoma cell lines in vitro.
Seifert M; Rech M; Meineke V; Tilgen W; Reichrath J
J Steroid Biochem Mol Biol; 2004 May; 89-90(1-5):375-9. PubMed ID: 15225804
[TBL] [Abstract][Full Text] [Related]
2. Cross-talk between vitamin D receptor (VDR)- and peroxisome proliferator-activated receptor (PPAR)-signaling in melanoma cells.
Sertznig P; Dunlop T; Seifert M; Tilgen W; Reichrath J
Anticancer Res; 2009 Sep; 29(9):3647-58. PubMed ID: 19667161
[TBL] [Abstract][Full Text] [Related]
3. No evidence for amplification of 25-hydroxyvitamin D-1alpha-OHase (1alpha-OHase) or 1,25-dihydroxyvitamin D-24-OHase (24-OHase) genes in malignant melanoma (MM).
Reichrath J; Rafi L; Rech M; Meineke V; Tilgen W; Seifert M
J Steroid Biochem Mol Biol; 2004 May; 89-90(1-5):163-6. PubMed ID: 15225766
[TBL] [Abstract][Full Text] [Related]
4. Analysis of the vitamin D system in cutaneous squamous cell carcinomas.
Reichrath J; Rafi L; Rech M; Mitschele T; Meineke V; Gärtner BC; Tilgen W; Holick MF
J Cutan Pathol; 2004 Mar; 31(3):224-31. PubMed ID: 14984574
[TBL] [Abstract][Full Text] [Related]
5. Effects of 1,25(OH)2D3, 25OHD3, and EB1089 on cell growth and Vitamin D receptor mRNA and 1alpha-hydroxylase mRNA expression in primary cultures of the canine prostate.
Kunakornsawat S; Rosol TJ; Capen CC; Omdahl JL; Leroy BE; Inpanbutr N
J Steroid Biochem Mol Biol; 2004 May; 89-90(1-5):409-12. PubMed ID: 15225811
[TBL] [Abstract][Full Text] [Related]
6. Signature of VDR miRNAs and epigenetic modulation of vitamin D signaling in melanoma cell lines.
Essa S; Reichrath S; Mahlknecht U; Montenarh M; Vogt T; Reichrath J
Anticancer Res; 2012 Jan; 32(1):383-9. PubMed ID: 22213330
[TBL] [Abstract][Full Text] [Related]
7. Analysis of the vitamin D system in basal cell carcinomas (BCCs).
Mitschele T; Diesel B; Friedrich M; Meineke V; Maas RM; Gärtner BC; Kamradt J; Meese E; Tilgen W; Reichrath J
Lab Invest; 2004 Jun; 84(6):693-702. PubMed ID: 15077124
[TBL] [Abstract][Full Text] [Related]
8. Vitamin D receptor and growth inhibition by 1,25-dihydroxyvitamin D3 in human malignant melanoma cell lines.
Evans SR; Houghton AM; Schumaker L; Brenner RV; Buras RR; Davoodi F; Nauta RJ; Shabahang M
J Surg Res; 1996 Feb; 61(1):127-33. PubMed ID: 8769954
[TBL] [Abstract][Full Text] [Related]
9. In vitro comparison of the vitamin D endocrine system in 1,25(OH)2D3-responsive and -resistant melanoma cells.
Reichrath J; Rech M; Moeini M; Meese E; Tilgen W; Seifert M
Cancer Biol Ther; 2007 Jan; 6(1):48-55. PubMed ID: 17172823
[TBL] [Abstract][Full Text] [Related]
10. Differential apoptotic response of human melanoma cells to 1 alpha,25-dihydroxyvitamin D3 and its analogues.
Danielsson C; Fehsel K; Polly P; Carlberg C
Cell Death Differ; 1998 Nov; 5(11):946-52. PubMed ID: 9846181
[TBL] [Abstract][Full Text] [Related]
11. Overexpression of vitamin D receptor indicates a good prognosis for cholangiocarcinoma: implications for therapeutics.
Seubwai W; Wongkham C; Puapairoj A; Khuntikeo N; Wongkham S
Cancer; 2007 Jun; 109(12):2497-505. PubMed ID: 17487855
[TBL] [Abstract][Full Text] [Related]
12. Mechanistic studies to evaluate the enhanced antiproliferation of human keratinocytes by 1alpha,25-dihydroxyvitamin D(3)-3-bromoacetate, a covalent modifier of vitamin D receptor, compared to 1alpha,25-dihydroxyvitamin D(3).
Chen ML; Ray S; Swamy N; Holick MF; Ray R
Arch Biochem Biophys; 1999 Oct; 370(1):34-44. PubMed ID: 10496974
[TBL] [Abstract][Full Text] [Related]
13. Altered SMRT levels disrupt vitamin D3 receptor signalling in prostate cancer cells.
Khanim FL; Gommersall LM; Wood VH; Smith KL; Montalvo L; O'Neill LP; Xu Y; Peehl DM; Stewart PM; Turner BM; Campbell MJ
Oncogene; 2004 Sep; 23(40):6712-25. PubMed ID: 15300237
[TBL] [Abstract][Full Text] [Related]
14. Analysis of the vitamin D system in cervical carcinomas, breast cancer and ovarian cancer.
Friedrich M; Rafi L; Mitschele T; Tilgen W; Schmidt W; Reichrath J
Recent Results Cancer Res; 2003; 164():239-46. PubMed ID: 12899526
[TBL] [Abstract][Full Text] [Related]
15. VDR-mediated gene expression patterns in resting human coronary artery smooth muscle cells.
Wu-Wong JR; Nakane M; Ma J; Ruan X; Kroeger PE
J Cell Biochem; 2007 Apr; 100(6):1395-405. PubMed ID: 17115413
[TBL] [Abstract][Full Text] [Related]
16. Clonal differences in expression of 25-hydroxyvitamin D(3)-1alpha-hydroxylase, of 25-hydroxyvitamin D(3)-24-hydroxylase, and of the vitamin D receptor in human colon carcinoma cells: effects of epidermal growth factor and 1alpha,25-dihydroxyvitamin D(3).
Bareis P; Kállay E; Bischof MG; Bises G; Hofer H; Pötzi C; Manhardt T; Bland R; Cross HS
Exp Cell Res; 2002 Jun; 276(2):320-7. PubMed ID: 12027461
[TBL] [Abstract][Full Text] [Related]
17. Modulation by cAMP of 1alpha,25-dihydroxyvitamin D3 sensitivity of murine erythroleukemia cells.
Waki M; Inaba M; Hiura Y; Nagasaki T; Imanishi Y; Ishimura E; Otani S; Nishizawa Y
Arch Biochem Biophys; 2001 Jul; 391(2):265-70. PubMed ID: 11437358
[TBL] [Abstract][Full Text] [Related]
18. 1,25-Dihydroxyvitamin D3 receptor as a marker of human colon carcinoma cell line differentiation and growth inhibition.
Shabahang M; Buras RR; Davoodi F; Schumaker LM; Nauta RJ; Evans SR
Cancer Res; 1993 Aug; 53(16):3712-8. PubMed ID: 8393379
[TBL] [Abstract][Full Text] [Related]
19. Mouse vitamin D-24-hydroxylase: molecular cloning, tissue distribution, and transcriptional regulation by 1alpha,25-dihydroxyvitamin D3.
Akeno N; Saikatsu S; Kawane T; Horiuchi N
Endocrinology; 1997 Jun; 138(6):2233-40. PubMed ID: 9165006
[TBL] [Abstract][Full Text] [Related]
20. 1 alpha, 25-dihydroxyvitamin D3 and all-trans-retinoic acid inhibit the growth of a lung cancer cell line.
Higashimoto Y; Ohata M; Nishio K; Iwamoto Y; Fujimoto H; Uetani K; Suruda T; Nakamura Y; Funasako M; Saijo N
Anticancer Res; 1996; 16(5A):2653-9. PubMed ID: 8917365
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]